Skip to main content
Log in

Analysis of the association of allelic variants of apolypoprotein E and interleukin 1 beta genes with multiple sclerosis in ethnic Tatars

  • Human Genetics
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) is a multifactorial disease of the central nervous system. The apolipoprotein E (APOE) and interleukin 1 β (IL1B) genes are considered to be candidate genes of MS. The aim of the study was to examine the hypothesis of the importance of APOE and IL1B gene polymorphisms in MS development in ethnic Tatars. DNA samples isolated by phenol-chloroform extraction from peripheral blood of 383 ethnic Tatars (120 MS patients and 263 healthy donors) were studied. 112C/R and 158R/C APOE gene polymorphisms as well as −511T/C IL1B gene polymorphism were analyzed by polymerase chain reaction (PCR) followed by PCR product digestion by endonuclease. Odds ratio (OR) values were used for evaluation of the relative risk of alleles and(or) genotype combinations. It has been shown that APOE*2/*3 genotype is associated with low risk of the disease development (OR = 0.20) in women. A combined effect of APOE and IL1B allelic variants has been discovered indicating the increased risk of the disease development in the carriers of APOE*4 and IL1B*T/*T alleles (OR = 4.76).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gusev, E.I., Boiko, A.N., Zavalishin, I.A., and Bykova, O.V., Contemporary Epidemiology of Multiple Sclerosis, in Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya (Multiple Sclerosis and Other Demyelinating Disorders), Moscow: Miklosh, 2004, pp. 8–29.

    Google Scholar 

  2. Bakhtiyarova, K.Z. and Magzhanov, R.V., Epidemiology of Multiple Sclerosis in the Republic of Bashkortostan, in Organizatsiya pomoshchi bol’nym rasseyannym sklerozom (Arrangement of Caring for Patients with Multiple Sclerosis), Proc. Workshop, Tomsk, 2003, pp. 3–5.

  3. Kulakova, O.G., Boiko, A.N., and Favorova, O.O., Cytokine Role in the Pathogeneses of Multiple Sclerosis, in Rasseyannyi skleroz i drugie demieliniziruyushchie zabolevaniya (Multiple Sclerosis and Other Demyelinating Disorders), Moscow: Miklosh, 2004, pp. 75–92.

    Google Scholar 

  4. Zavalishin, I.A., Zakharova, M.N., Zhuchenko, T.D., and Peresedova, A.V., Etiology and Pathogeneses of Multiple Sclerosis, in Rasseyannyi skleroz: Izbrannye voprosy teorii i praktiki (Multiple Sclerosis: Selected Issues in Theory and Practice), Moscow: Res. Inst. Nevrologii RAMN, 2000, pp. 537–579.

    Google Scholar 

  5. Ebers, G.C., Bulman, D.E., Sadovnick, A.D., et al., A Population-Based Study of Multiple Sclerosis in Twins, New England J. Med., 1986, vol. 315, pp. 1638–1642.

    Article  CAS  Google Scholar 

  6. Compston, A. and Sadovnick, A.D., Epidemiology and Genetics of Multiple Sclerosis, Curr. Opin. Neurol. Neurosurg., 1992, vol. 5, pp. 175–181.

    CAS  PubMed  Google Scholar 

  7. Dyment, D.A., Ebers, G.C., and Sadovnick, A.D., Genetics of Multiple Sclerosis, Lancet Neurol., 2004, vol. 3, pp. 104–110.

    Article  CAS  PubMed  Google Scholar 

  8. Graham, D.I., Horsburgh, K., Nicoll, J., et al., Apolipoprotein E and the Response of the Brain to Injury, Acta. Neurochir., 1999, vol. 73(suppl.), pp. 89–92.

    CAS  Google Scholar 

  9. Han, X., The Role of Apolipoprotein E in Lipid Metabolism in the Central Nervous System, Cell Mol. Life Sci., 2004, vol. 61, pp. 1896–1906.

    Article  CAS  PubMed  Google Scholar 

  10. Weisgraber, K., Innerarity, T., and Mahley, R., Abnormal Lipoprotein Receptor-Binding Activity of the Human apoE Apoprotein Due to Cysteine-Arginine Interchange at a Single Site, J. Biol. Chem., 1989, vol. 257, pp. 2518–2521.

    Google Scholar 

  11. Moynagh, P.N., The Interleukin-1 Signalling Pathway in Astrocytes: A Key Contributor to Inflammation in the Brain, J. Anat., 2005, vol. 207, pp. 265–269.

    Article  CAS  PubMed  Google Scholar 

  12. Moos, V., Rudwaleit, M., Herzog, V., et al., Association of Genotypes Affecting the Expression of Interleukin-1beta or Interleukin-1 Receptor Antagonist with Osteoarthritis, Arthritis Rheum., 2000, vol. 43, pp. 2417–2422.

    Article  CAS  PubMed  Google Scholar 

  13. Pociot, F., Molvig, J., Wogensen, L., et al., TaqI Polymorphism in the Human Interleukin-1 (IL-1) Gene Correlates with IL-1 Secretion in Vitro, Eur. J. Clin. Invest., 1992, vol. 22, pp. 396–402.

    Article  CAS  PubMed  Google Scholar 

  14. McDonald, W., Compston, A., Edan, G., et al., Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis, Ann. Neurol., 2001, vol. 50, pp. 121–127.

    Article  CAS  PubMed  Google Scholar 

  15. Hixson, J.E. and Vernier, D.T., Restriction Isotyping of Human Apolipoprotein E by Gene Amplification and Cleavage with HhaI, J. Lipid Res., 1990, vol. 31, pp. 545–548.

    CAS  PubMed  Google Scholar 

  16. Kato, S., Onda, M., Yamada, S., et al., Association of the Interleukin-1 Genetic Polymorphism and Gastric Cancer Risk in Japanese, J. Gastroenterol., 2001, vol. 36, pp. 696–699.

    Article  CAS  PubMed  Google Scholar 

  17. Roff, P. and Bentzen, P., The Statistical Analysis of DNA Polymorphism Chi 2 and Problem of Small Samples, Mol. Biol. Evol., 1989, vol. 6, pp. 539–545.

    CAS  PubMed  Google Scholar 

  18. Zhivotovsky, L.A., Populyatsionnaya biometriya (Population Biometry), Moscow: Nauka, 1991.

    Google Scholar 

  19. Bland, J.M. and Altman, D.G., The Odds Ratio, Brit. Med. J., 2000, vol. 320, p. 1468.

    Article  CAS  PubMed  Google Scholar 

  20. Poirier, J., Apolipoprotein E in Animal Models of CNS Injury and in Alzheimer’s Disease, Trends Neurosci., 1994, vol. 17, pp. 525–530.

    Article  CAS  PubMed  Google Scholar 

  21. Han, X., Cheng, H., Fryer, J., et al., Novel Role for Apolipoprotein E in the Central Nervous System: Modulation of Sulfatide Content, J. Biol. Chem., 2003, vol. 278, pp. 8043–8051.

    Article  CAS  PubMed  Google Scholar 

  22. Gailard, O., Gervais, A., Meillet, D., et al., Apolipoprotein E and Multiple Sclerosis: A Biochemical and Genetic Investigation, J. Neurol. Sci., 1998, vol. 158, pp. 180–186.

    Article  Google Scholar 

  23. Laskowitz, D.T., Lee, D.M., Schmechel, D., and Staats, H.F., Altered Immune Responses in Apolipoprotein E-Deficient Mice, J. Lipid Res., 2000, vol. 41, p. 613.

    CAS  PubMed  Google Scholar 

  24. Nathan, B.P., Bellosta, S., Sanan, D.A., et al., Differential Effects of Apolipoprotein E3 and E4 on Neuronal Growth in Vitro, Science, 1994, vol. 264, pp. 850–852.

    Article  CAS  PubMed  Google Scholar 

  25. Pedersen, W.A., Chan, S.L., and Mattson, M.P., A Mechanism for the Neuroprotective Effect of Apolipoprotein E: Isoform-Specific Modification by the Lipid Peroxidation Product 4-Hydroxynonenal, J. Neurochem., 2000, vol. 74, pp. 1426–1433.

    Article  CAS  PubMed  Google Scholar 

  26. Hashimoto, Y., Jiang, H., Niikura, T., et al., Neuronal Apoptosis by Apolipoprotein E4 Through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases, J. Neurosci., 2000, vol. 20, pp. 8401–8409.

    CAS  PubMed  Google Scholar 

  27. Buttini, M., Orth, M., Bellosta, S., et al., Expression of Human Apolipoprotein E3 or E4 in the Brains of Apoe-/-Mice: Isoform-Specific Effects on Neurodegeneration, J. Neurosci., 1999, vol. 19, pp. 4867–4880.

    CAS  PubMed  Google Scholar 

  28. DeKroon, R., Mihovilovic, M., Goodger, Z., et al., ApoE Genotype-Specific Inhibition of Apoptosis, J. Lipid Res., 2003, vol. 44, pp. 1566–1573.

    Article  CAS  PubMed  Google Scholar 

  29. Arendt, T., Schindler, C., Bruckner, M.K., et al., Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein e4 Allele, J. Neurosci., 1997, vol. 17, pp. 516–529.

    CAS  PubMed  Google Scholar 

  30. Roses, A.D. and Saunders, A., Head Injury, Amyloid Beta and Alzheimer’s Disease, Nat. Med., 1995, vol. 1, pp. 603–604.

    Article  CAS  PubMed  Google Scholar 

  31. Schmidt, S., Barcellos, L.F., DeSombre, K., et al., Association of Polymorphisms in the Apolipoprotein E Region with Susceptibility to and Progression of Multiple Sclerosis, Am. J. Hum. Genet., 2002, vol. 70, pp. 708–717.

    Article  CAS  PubMed  Google Scholar 

  32. Evangelou, N., Jackson, M., Beeson, D., and Palace, J., Association of the APOE e4 Allele with Disease Activity in Multiple Sclerosis, J. Neurol. Neurosurg. Psychiatry, 1999, vol. 67, pp. 203–205.

    Article  CAS  PubMed  Google Scholar 

  33. Kantarci, O.H., Hebrink, D.D., Achenbach, S.J., et al., Association of APOE Polymorphisms with Disease Severity in MS Is Limited to Women, Neurology, 2004, vol. 62, pp. 811–814.

    CAS  PubMed  Google Scholar 

  34. Raber, J., Bongers, G., LeFevour, A., et al., Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits, J. Neurosci., 2002, vol. 22, pp. 5204–5209.

    CAS  PubMed  Google Scholar 

  35. Zofkova, I., Zajckova, K., Hill, M., and Horinekl, A., Apolipoprotein E Gene Determines Serum Testosterone and Dehydroepiandrosterone Levels in Postmenopausal Women, Eur. J. Endocrinol., 2002, vol. 147, pp. 503–506.

    Article  CAS  PubMed  Google Scholar 

  36. Lahita, R.G., Gender and the Immune System, J. Gend. Specif. Med., 2000, vol. 3, pp. 19–22.

    CAS  PubMed  Google Scholar 

  37. Weatherby, S., Mann, C., Fryer, A., et al., No Association between the APOE e4 Allele and Outcome and Susceptibility in Primary Progressive Multiple Sclerosis, J. Neurol. Neurosurg. Psychiatry, 2000, vol. 68, pp. 532–541.

    Article  Google Scholar 

  38. Sedano, M., Calmarza, P., Perez, L., and Trejo, J., No Association of Apolipoprotein E4 Genotype with Faster Progression or Less Recovery of Relapses in a Spanish Cohort of Multiple Sclerosis, Mult. Scler., 2006, vol. 12, pp. 13–18.

    Article  CAS  PubMed  Google Scholar 

  39. Burwick, R., Ramsay, P., Haines, J., et al., APOE Epsilon Variation in Multiple Sclerosis Susceptibility and Disease Severity: Some Answers, Neurology, 2006, vol. 66, pp. 1373–1383.

    Article  CAS  PubMed  Google Scholar 

  40. Moynagh, P., The Interleukin-1 Signaling Pathway in Astrocytes: A Key Contributor to Inflammation in the Brain, J. Anat., 2005, vol. 207, pp. 265–269.

    Article  CAS  PubMed  Google Scholar 

  41. Bidwell, J., Keen, L., Gallagher, G., et al., Cytokine Gene Polymorphism in Human Disease: On-Line Data-bases, Supplement 1, Genes Immunity, 2001, vol. 2, pp. 61–70.

    Article  CAS  PubMed  Google Scholar 

  42. Laurincova, B., Interleukin-1 Family: From Genes to Human Disease, Acta Univ. Palacki Olomuc Fac. Med., 2000, vol. 143, pp. 19–29.

    CAS  PubMed  Google Scholar 

  43. Ferri, C., Sciacca, F., and Grimaldi, L., Lack of Association between IL-1α and IL-1β Promoter Polymorphisms and Multiple Sclerosis, J. Neurol. Neurosurg. Psychiatry, 2003, vol. 69, pp. 564–565.

    Article  Google Scholar 

  44. Hooper-van Veen, T., Schrijver, H., Zwiers, A., et al., The Interleukin-1 Gene Family in Multiple Sclerosis Susceptibility and Disease Course, Mult. Scler., 2003, vol. 9, pp. 535–539.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. E. Mustafina.

Additional information

Original Russian Text © O.E. Mustafina, K.Z. Bakhtijarova, A.M. Mikhailova, I.A. Tuktarova, A.N. Khusainova, T.R. Nasibullin, R.V. Magjanov, 2008, published in Genetika, 2008, Vol. 44, No. 3, pp. 407–413.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mustafina, O.E., Bakhtijarova, K.Z., Mikhailova, A.M. et al. Analysis of the association of allelic variants of apolypoprotein E and interleukin 1 beta genes with multiple sclerosis in ethnic Tatars. Russ J Genet 44, 350–356 (2008). https://doi.org/10.1134/S1022795408030174

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795408030174

Keywords

Navigation